Commentary

The New Cancer Stats Might Look Like a Death Sentence. They Aren’t.


 

Fighting Fear With Routine

Treating cancer as a normal part of young people’s healthcare means helping them envision the disease as a condition that can be treated, much like a diagnosis of diabetes or high cholesterol. This mindset shift means quickly following up on a concerning symptom or screening result and reducing the time to start treatment if needed. And with treatment options and success rates for some cancers being better than ever, survivorship support must be built into every treatment plan from the start. Before treatment begins, healthcare providers should make time to talk about sometimes-overlooked key topics, such as reproductive options for people whose fertility may be affected by their cancer treatment, about plans for returning to work during or after treatment, and finding the right mental health support.

Where we can’t prevent cancer, both primary care providers and oncologists can work together to help patients receive the right diagnosis and treatment as quickly as possible. Knowing insurance coverage has a direct effect on how early cancer is caught, for example, younger people need support in understanding and accessing benefits and resources that may be available through their existing healthcare channels, like some employer-sponsored health plans. Even if getting treated for cancer is inevitable for some, taking immediate action to get screened when it’s appropriate is the best thing we can do to lessen the impact of these rising cancer incidences across the country. At the end of the day, being afraid of cancer doesn’t decrease the chances of getting sick or dying from it. Proactive screening and early detection do.

Brockman, Genetic Counselor, Color Health, Buffalo, New York, has disclosed no relevant financial relationships.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Cancer Cases, Deaths in Men Predicted to Surge by 2050
MDedge Dermatology
Study Indicates Skin Cancer Risk Elevated Among Veterans
MDedge Dermatology
Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?
MDedge Dermatology
Cancer Risk: Are Pesticides the New Smoking?
MDedge Dermatology
Transient Eruption of Verrucous Keratoses During Encorafenib Therapy: Adverse Event or Paraneoplastic Phenomenon?
MDedge Dermatology
Inspection of Deep Tumor Margins for Accurate Cutaneous Squamous Cell Carcinoma Staging
MDedge Dermatology
AACR Cancer Progress Report: Big Strides and Big Gaps
MDedge Dermatology
Does Medicare Advantage Offer Higher-Value Chemotherapy?
MDedge Dermatology
Popular Weight Loss Drugs Now for Patients With Cancer?
MDedge Dermatology
‘Cancer Doesn’t Wait’: How Prior Authorization Harms Care
MDedge Dermatology